FAM185A expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 7.536400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
7.567800E-01
Normal-vs-Stage2
7.542400E-01
Normal-vs-Stage3
1.385790E-01
Normal-vs-Stage4
7.479800E-01
Stage1-vs-Stage2
3.908800E-01
Stage1-vs-Stage3
3.427500E-02
Stage1-vs-Stage4
9.960200E-01
Stage2-vs-Stage3
1.069810E-01
Stage2-vs-Stage4
4.780800E-01
Stage3-vs-Stage4
3.660100E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
7.737200E-01
Normal-vs-AfricanAmerican
9.125200E-01
Normal-vs-Asian
6.730800E-01
Caucasian-vs-AfricanAmerican
8.620400E-01
Caucasian-vs-Asian
6.793800E-01
AfricanAmerican-vs-Asian
7.345800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
7.549000E-01
Normal-vs-Female
7.546600E-01
Male-vs-Female
9.902800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
8.937800E-01
Normal-vs-Age(41-60Yrs)
9.989800E-01
Normal-vs-Age(61-80Yrs)
5.601200E-01
Normal-vs-Age(81-100Yrs)
6.107600E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
8.646800E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
4.567600E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
7.206800E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
3.716200E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
3.037800E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
3.358400E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
9.368000E-01
Normal-vs-Daily Drinker
5.442200E-01
Normal-vs-Weekly Drinker
9.324800E-01
Normal-vs-Occasional Drinker
4.259600E-01
Normal-vs-Social Drinker
8.373800E-01
Non Drinker-vs-Daily Drinker
2.058000E-01
Non Drinker-vs-Weekly Drinker
7.575000E-01
Non Drinker-vs-Occasional Drinker
1.763250E-01
Non Drinker-vs-Social Drinker
6.377200E-01
Daily Drinker-vs-Weekly Drinker
4.616400E-01
Daily Drinker-vs-Occasional Drinker
8.894000E-01
Daily Drinker-vs-Social Drinker
4.361800E-01
Weekly Drinker-vs-Occasional Drinker
5.296200E-01
Weekly Drinker-vs-Social Drinker
9.188400E-01
Occasional Drinker-vs-Social Drinker
4.286600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
7.506300E-02
Normal-vs-Grade 2
2.162100E-03
Normal-vs-Grade 3
1.070000E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
1.269540E-02
Grade 1-vs-Grade 3
1.140280E-02
Grade 1-vs-Grade 4
7.506300E-02
Grade 2-vs-Grade 3
3.402000E-01
Grade 2-vs-Grade 4
2.162100E-03
Grade 3-vs-Grade 4
1.070000E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
7.162800E-01
Normal-vs-NonDiabetic
7.538400E-01
Diabetic-vs-NonDiabetic
6.740000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
9.914800E-01
Normal-vs-NoPancreatitis
6.976000E-01
Pancreatitis-vs-NoPancreatitis
4.394800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
6.509200E-01
Normal-vs-N1
8.075400E-01
N0-vs-N1
6.396400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
8.908800E-01
Normal-vs-TP53-NonMutant
9.163600E-01
TP53-Mutant-vs-TP53-NonMutant
4.207200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
